Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted Psychotherapy for Eating Disorders
NCT04454684Phase 2Withdrawn
- Sponsor
- Lykos Therapeutics
- Start
- Feb 2026
- Primary completion
- Aug 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of midomafetamine in anorexia nervosa restricting type (AN-R), binge eating disorder (BED), sponsored by Lykos Therapeutics. Planned start Feb 2026; status: withdrawn.
02
Drugs
midomafetamine
03
Conditions
anorexia nervosa restricting type (AN-R)binge eating disorder (BED)
Beyond the preview
Go deeper on NCT04454684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454684.